Quarterly report · Q1
8086.TEDINET S100RNZX
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥140.6bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥545.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥127.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥7.3bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥3.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥8.9bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥15.3bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.3bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥9.4bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.1bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥5.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥1.04T | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥1.03T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥947.6bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥791.5bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥785.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥249.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥242.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥217.3bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥88.1bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥89.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥25.14 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.05 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.35 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.27 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.85 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.66 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 20.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥189m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥971m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | ¥3m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥14.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥14.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥8.2bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥109.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥108.0bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥11.8bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥27.8bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥17.4bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥10.3bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.2bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥16.6bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥15.0bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥566m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥153.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥140.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥13.5bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥155.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥140.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥15.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥855m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥211m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥7.1bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥99.3bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥97.7bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥8.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥23.2bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥17.9bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥407m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥12.2bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥136.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥8.4bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥137.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥10.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 446
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0453 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 7763000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 7763000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0453 | |
| Cash and deposits | Prior1YearInstant | 89678000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 88058000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 160271000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 160485000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 137774000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 140426000000 | JPY |
| Work in process | Prior1YearInstant | 17427000000 | JPY |
| Work in process | CurrentQuarterInstant | 19238000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 52592000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 55962000000 | JPY |
| Other ca | Prior1YearInstant | 35701000000 | JPY |
| Other ca | CurrentQuarterInstant | 38588000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -4157000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -3757000000 | JPY |
| Current assets | Prior1YearInstant | 489289000000 | JPY |
| Current assets | CurrentQuarterInstant | 499003000000 | JPY |
| Buildings and structures | Prior1YearInstant | 287677000000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 287563000000 | JPY |
| Accumulated depreciation and impairment loss buildings and structures | Prior1YearInstant | -147531000000 | JPY |
| Accumulated depreciation and impairment loss buildings and structures | CurrentQuarterInstant | -147842000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 140145000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 139720000000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 360642000000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 371255000000 | JPY |
| Accumulated depreciation and impairment loss machinery equipment and vehicles | Prior1YearInstant | -265162000000 | JPY |
| Accumulated depreciation and impairment loss machinery equipment and vehicles | CurrentQuarterInstant | -268365000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 95480000000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 102889000000 | JPY |
| Land | Prior1YearInstant | 47123000000 | JPY |
| Land | CurrentQuarterInstant | 47137000000 | JPY |
| Lease assets ppe | Prior1YearInstant | 35947000000 | JPY |
| Lease assets ppe | CurrentQuarterInstant | 35803000000 | JPY |
| Accumulated depreciation lease assets ppe | Prior1YearInstant | -13115000000 | JPY |
| Accumulated depreciation lease assets ppe | CurrentQuarterInstant | -13484000000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 22831000000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 22318000000 | JPY |
| Construction in progress | Prior1YearInstant | 103336000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 105488000000 | JPY |
| Other ppe | Prior1YearInstant | 89858000000 | JPY |
| Other ppe | CurrentQuarterInstant | 92438000000 | JPY |
| Accumulated depreciation and impairment loss other ppe | Prior1YearInstant | -66224000000 | JPY |
| Accumulated depreciation and impairment loss other ppe | CurrentQuarterInstant | -67788000000 | JPY |
| Other net ppe | Prior1YearInstant | 23633000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 24650000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 432550000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |